Search all ERS
Interstitial Lung Diseases
Respiratory Critical Care
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
ERJ Open Research
European Lung White Book
All ERS guidelines
Global Lung Function Initiative
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
The use of online visual analogue scales in idiopathic pulmonary fibrosis
Catharina C. Moor, Remy L.M. Mostard, Jan C. Grutters, Paul Bresser, Marlies S. Wijsenbeek
Eur Respir J, 59 (1) 2101531; 10.1183/13993003.01531-2021
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Catharina C. Moor, Remy L.M. Mostard, Jan C. Grutters, Paul Bresser, Marlies S. Wijsenbeek. The use of online visual analogue scales in idiopathic pulmonary fibrosis. Eur Respir J, 59 (1) 2101531; 10.1183/13993003.01531-2021
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
No comment yet.
to comment this presentation.
Related content which might interest you:
Endoscopic lung volume reduction with endobronchial valves in very low DLCO patients
Amazing pleiotropic effects of azithromycin
The effect of community lung rehabilitation guidance on the quality of life of patients with COPD.
Related content which might interest you:
Patient-reported outcomes in idiopathic pulmonary fibrosis; validity and reliability of visual analogue scales
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Negative visual representation of chronic obstructive pulmonary disease occurs online
Source: ERJ Open Res, 6 (4) 00549-2020; 10.1183/23120541.00549-2020
Item generation for a patient reported outcome measure (PRoM) in idiopathic pulmonary fibrosis (IPF): Application of consensus methods
Source: International Congress 2015 – IPF: clinical aspects
Visual and fully-automated CT analysis in acute exacerbations of idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Cost-effectiveness of an online homemonitoring program in idiopathic pulmonary fibrosis
Source: Virtual Congress 2021 – Biomarkers and e-health in idiopathic interstitial pneumonia
A comparison of published multidimensional indices to predict outcome in idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (1) 00096-2016; 10.1183/23120541.00096-2016
A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis
Source: Eur Respir J 2010; 36: 1067-1072
Clinical burden of idiopathic pulmonary fibrosis (IPF): physician and patient perception
Source: Virtual Congress 2020 – Clinical aspects of idiopathic pulmonary fibrosis
A global registry for idiopathic pulmonary fibrosis: the time is now
Source: Eur Respir J 2014; 44: 273-276
Does a visual analogue scale assist in the assessment of the use of nebulised bronchodilators for moderate/severe COPD patients?
Source: Eur Respir J 2002; 20: Suppl. 38, 622s
The changing treatment landscape in idiopathic pulmonary fibrosis
Source: Eur Respir Rev 2015; 24: 65-68
The development of a measure to better understand patient experiences with pirfenidone and nintedanib for the treatment of idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
mMRC dyspnoea scale indicates impaired quality of life and increased pain in patients with idiopathic pulmonary fibrosis
Source: ERJ Open Res, 3 (4) 00084-2017; 10.1183/23120541.00084-2017
Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation
Source: Eur Respir J 2012; 40: 794-795
Initial clinical experience with nintedanib for treatment of idiopathic pulmonary fibrosis (IPF): About 20 cases
Source: International Congress 2015 – IPF: from bench to bedside
An electronic nose can sniff out idiopathic pulmonary fibrosis.
Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia
The reliability and validity of the 4 metre gait speed (4MGS) in idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2016 – Best abstracts in exercise capacity and testing in chronic lung diseases
The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis
Source: Eur Respir J 2005; 25: 96-103
Comparison of densitometric and visual scoring in the assessment of severity of idiopathic fibrotic interstitial pneumonias: Preliminary observations
Source: International Congress 2015 – New insights into IIPs